Raptor submits NDA for Cysteamine Bitartrate delayed-release capsules
Raptor has appealed for priority review of the NDA, which, if granted, could lead to a decision for marketing approval of RP103 in the fourth calendar quarter of
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
MemberMATCH solution is designed to centralize critical data sources, reducing and eliminating manual processing, thereby increasing compliance. The MemberMATCH membership automation solution also provides key functions, including a